British Journal of Cancer · 2010 · 47 citations · 23 references
Malignant pleural mesothelioma (MPM) is a rare but fatal tumour. Although most MPM patients show pleural effusion at even the early stage, it is hard to diagnose as MPM at the early stage because a sensitive and reliable diagnostic marker for MPM has not been found in plasma or pleural effusion. In this study, we investigated whether intelectin-1 was specifically contained in MPM cells and the pleural effusion of MPM patient by immunohistochemistry, western blotting, and enzyme-linked immunosorbent assay. Malignant pleural mesothelioma cell lines, but not lung adenocarcinoma cell lines, secreted intelectin-1. In immunohistochemistry, epithelioid-type MPMs, but neither pleura-invading lung adenocarcinomas nor reactive mesothelial cells near the lung adenocarcinomas, were stained with anti-intelectin antibodies. Pleural effusion of MPM patients contained a higher concentration of intelectin-1 than that of lung cancer patients. These results suggest that detection of intelectin-1 may be useful for a differential diagnosis of epithelioid-type MPM in immunohistochemistry and that a high concentration of intelectin-1 in pleural effusion can be used as a new marker for clinical diagnosis of MPM.
23
David J. Sugarbaker, Raja M. Flores, Michael T. Jaklitsch et al. · Journal of Thoracic and Cardiovascular Surgery · 1999 · 980 citations · Full text
Surgical Oncology, Resection Margins, Extrapleural Nodal Status +6
The European mesothelioma epidemic
Julian Peto, Adriano Decarli, Carlo La Vecchia et al. · British Journal of Cancer · 1999 · 896 citations · Full text
Mesothelin-family proteins and diagnosis of mesothelioma
Bruce Robinson, Jenette Creaney, Richard Lake et al. · The Lancet · 2003 · 530 citations